Genetic requirement for hemagglutinin glycosylation and its implications for influenza a H1N1 virus evolution

Journal of Virology

Volumn 87, Issue 13, 2013, Pages 7539-7549

  Kim, Jin Il ^a   Lee, Ilseob ^a   Park, Sehee ^a   Hwang, Min Woong ^a   Bae, Joon Yong ^a   Lee, Sangmoo ^a   Heo, Jun ^a   Park, Mee Sook ^a   García Sastre, Adolfo ^b   Park, Man Seong ^a  

^a Hallym University   (South Korea)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; BODY WEIGHT; DOGS; EVOLUTION, MOLECULAR; GLYCOSYLATION; GUINEA PIGS; HEK293 CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED C57BL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 84880362193     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00373-13     Document Type: Article

References (51)

1. World Health Organization. 2012. Fact sheet on influenza. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentrefactsheets/fs211/en/index.html.
2. Palese P. 2004. Influenza: old and new threats. Nat. Med. 10:S82-S87.
3. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125.
4. Neumann G, Kawaoka Y. 2011. The first influenza pandemic of the new millennium. Influenza Other Respir. Viruses 5:157-166.
5. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
6. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
7. 2009 Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58:521-524.
8. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ. 2009. Antigenic and genetic characteristics of swineorigin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
9. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Jr, Wilson IA. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357-360.
10. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. 2004. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866 -1870.
11. Shope RE. 1936. The incidence of neutralizing antibodies for swine influenza virus in the sera of human beings of different ages. J. Exp. Med. 63:669-684.
12. Wei CJ, Boyington JC, Dai K, Houser KV, Pearce MB, Kong WP, Yang ZY, Tumpey TM, Nabel GJ. 2010. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2:24ra21.
13. Cohen J. 2010. Swine flu pandemic. What's old is new: 1918 virus matches 2009 H1N1 strain. Science 327:1563-1564.
14. Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villan E, Palese P, Basler CF, Garcia-Sastre A. 2010. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 6:e1000745. doi:10.1371 /journal.ppat.1000745.
15. Gerhard W, Webster RG. 1978. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J. Exp. Med. 148:383-392.
16. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, Wilson IA, Wiley DC. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 81:1779 -1783.
17. Schulze IT. 1997. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J. Infect. Dis. 176(Suppl 1):S24 -S28.
18. Kim JI, Park MS. 2012. N-linked glycosylation in the hemagglutinin of influenza A viruses. Yonsei Med. J. 53:886-893.
19. Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbo P, Ince WL, Bennink JR, Yewdell JW. 2011. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc. Natl. Acad. Sci. U. S. A. 108:E1417-1422.
20. Das SR, Puigbo P, Hensley SE, Hurt DE, Bennink JR, Yewdell JW. 2010. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog. 6:e1001211. doi:10.1371 /journal.ppat.1001211.
21. Sun S, Wang Q, Zhao F, Chen W, Li Z. 2011. Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS One 6:e22844. doi:10.1371/journal.pone.0022844.
22. Xu R, McBride R, Nycholat CM, Paulson JC, Wilson IA. 2012. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J. Virol. 86:982-990.
23. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493- 497.
24. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679 -9682.
25. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326:734 -736.
26. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, Ha Y, Vasisht N, Steinhauer DA, Daniels RS, Elliot A, Wiley DC, Skehel JJ. 2004. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303:1838 -1842.
27. Soundararajan V, Tharakaraman K, Raman R, Raguram S, Shriver Z, Sasisekharan V, Sasisekharan R. 2009. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nat. Biotechnol. 27:510 -513.
28. Kim JI, Lee I, Park S, Park M-S. 2012. Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus. BMB Rep. 45:653- 658.
29. Medeiros R, Naffakh N, Manuguerra JC, van der Werf S. 2004. Binding of the hemagglutinin from human or equine influenza H3 viruses to the receptor is altered by substitutions at residue 193. Arch. Virol. 149:1663- 1671.
30. Maines TR, Chen LM, Van Hoeven N, Tumpey TM, Blixt O, Belser JA, Gustin KM, Pearce MB, Pappas C, Stevens J, Cox NJ, Paulson JC, Raman R, Sasisekharan R, Katz JM, Donis RO. 2011. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 413:139 -147.
31. Scott JN, Nucci NV, Vanderkooi JM. 2008. Changes in water structure induced by the guanidinium cation and implications for protein denaturation. J. Phys. Chem. A 112:10939 -10948.
32. Kilbourne ED. 1977. Influenza pandemics in perspective. JAMA 237: 1225-1228.
33. Reperant LA, Kuiken T, Osterhaus AD. 2012. Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans. Vaccine 30:4419-4434.
34. Ito T, Kawaoka Y. 2000. Host-range barrier of influenza A viruses. Vet. Microbiol. 74:71-75.
35. Belser JA, Maines TR, Tumpey TM, Katz JM. 2010. Influenza A virus transmission: contributing factors and clinical implications. Expert Rev. Mol. Med. 12:e39.
36. Thompson CI, Barclay WS, Zambon MC, Pickles RJ. 2006. Infection of human airway epithelium by human and avian strains of influenzaAvirus. J. Virol. 80:8060-8068.
37. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531- 569.
38. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 103:9988 -9992.
39. Deshpande KL, Fried VA, Ando M, Webster RG. 1987. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. U. S. A. 84:36-40.
40. Roberts PC, Garten W, Klenk HD. 1993. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J. Virol. 67:3048 -3060.
41. Tsuchiya E, Sugawara K, Hongo S, Matsuzaki Y, Muraki Y, Li ZN, Nakamura K. 2002. Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J. Gen. Virol. 83:1137-1146.
42. Ohuchi M, Ohuchi R, Feldmann A, Klenk HD. 1997. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 71:8377- 8384.
43. Wagner R, Wolff T, Herwig A, Pleschka S, Klenk HD. 2000. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J. Virol. 74:6316- 6323.
44. Daniels RS, Douglas AR, Skehel JJ, Wiley DC. 1985. Antigenic and amino acid sequence analyses of influenza viruses of the H1N1 subtype isolated between 1982 and 1984. Bull. World Health Organ. 63:273-277.
45. World Health Organization. 1986. Recommended composition of influenza virus vaccines for use in the 1986-1987 season. Wkly. Epidemiol. Rec. 61:61- 64.
46. World Health Organization. 1986. Composition of influenza virus vaccines for use in the 1986-1987 season: an update. Wkly. Epidemiol. Rec. 61:237-244.
47. Centers for Disease Control and Prevention. 1986. Monovalent influenza A(H1N1) vaccine, 1986-1987. MMWR Morb. Mortal. Wkly. Rep. 35:517-521.
48. World Health Organization. 1996. WHO influenza surveillance. Wkly. Epidemiol. Rec. 71:353-357.
49. Sun S, Wang Q, Zhao F, Chen W, Li Z. 2012. Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses. PLoS One 7:e32119. doi:10.1371/journal.pone.0032119.
50. World Health Organization. 1997. Recommended composition of influenza virus vaccines for use in the 1997-1998 season. Wkly. Epidemiol. Rec. 72:57- 61.
51. World Health Organization. 1998. Recommended composition of influenza virus vaccines for use in the 1998-1999 season. Wkly. Epidemiol. Rec. 73:56-61.